⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
13,340
Total Claims
$1.2M
Drug Cost
699
Beneficiaries
$1,666
Cost/Patient
Risk Score Breakdown 3/100
Low (0)Moderate (15)Elevated (30)High (50+)
High fills per patient+3
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+9%
Cost per patient vs peers
$1,666 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 11,431 claims · $186K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 415 | $301K |
| Dapagliflozin Propanediol | 171 | $126K |
| Rivaroxaban | 139 | $106K |
| Empagliflozin | 71 | $44K |
| Sitagliptin Phosphate | 54 | $38K |
| Sacubitril/Valsartan | 36 | $37K |
| Sitagliptin Phos/Metformin Hcl | 49 | $33K |
| Sitagliptin Phos/Metformin Hcl | 38 | $32K |
| Dapaglifloz Propaned/Metformin | 43 | $31K |
| Candesartan Cilexetil | 309 | $28K |
| Levothyroxine Sodium | 337 | $23K |
| Semaglutide | 23 | $22K |
| Linagliptin | 24 | $18K |
| Evolocumab | 28 | $16K |
| Atorvastatin Calcium | 1,488 | $15K |
Prescribing Profile
Patient Profile
73
Avg Age
59%
Female
2.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About